Section I. Overview

1. An overview of genome editing in cardiovascular and metabolic diseases

Section II. Bioinformatics

2. Bioinformatics research methodology of genome editing in cardiovascular and metabolic diseases

3. Online databases of genome editing in cardiovascular and metabolic diseases

4. Application of systems biology for genome editing involved in regulating of cardiovascular and metabolic diseases

5. Bioinformatics for reducing off-targets in cardiovascular and metabolic diseases

Section III. Genome editing in cardiovascular disease

6. Genome editing and cardiac regeneration

7. Genome editing and myocardial development

8. Genome editing and heart failure

9. Genome editing and pathological cardiac hypertrophy

10. Genome editing and cardiac remodeling

11. Genome editing and diabetic cardiomyopathy

12. Genome editing and cardiac arrhythmias

13. Genome editing and atrial fibrillation

14. Genome editing and muscle atrophy

Section IV. Genome editing in metabolic diseases

15. Genome editing and obesity

16. Genome editing and fatty liver

17. Genome editing and diabetes

18. Genome editing and gout

19. Genome editing and protein energy malnutrition

Section V. Therapeutic implications

20. Genome therapy and cardiovascular diseases

21. Therapeutics in metabolic diseases

22. Gene editing and human iPSCs in cardiovascular and editing diseases

Section VI. Future Prospects

23. Prospective advances in genome editing investigation

Dr. Junjie Xiao is the Vice Dean of the School of Life Science and also of the Medical School at Shanghai University. He is the Associate Editor of the Journal of Cardiovascular Translational Research, BMC Sports and Science, Medicine& Rehabilitation, and a member of the editorial board of BMC Medicine. He is the author or co-author of numerous scientific articles in various journals, including Cell Metabolism, Nature Communications, Annual Review of Genomics and Human Genetics, Circulation, and Theranostics. His major research interest is exercise and myocardial protection, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating heart failure.